Belzutifan is a kind of HIF-2α pseudoinhibitor. It’s used to treat VHL-linked renal cell carcinoma. It works by cutting down tumor hypoxia signals.
The pill comes in 40 mg film-coated form. You’re supposed to take 120 mg of it once daily. Each bottle has 90 tablets.
It makes it easy for patients to follow the dose schedule.
Reviews
There are no reviews yet.